Mitchell Chan

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mitchell Chan:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Financial Officer Common Stock 127,717 $1,839,137 $14.40 06 Jan 2026 Direct
Avalo Therapeutics, Inc. Director Restricted Stock Units 6,333 $53,577 $8.46 28 Mar 2025 Direct
Avalo Therapeutics, Inc. Director Common Stock 3,167 $26,793 $8.46 28 Mar 2025 Direct
REGENXBIO Inc. Chief Financial Officer Stock Options (Right to buy) 39,650 06 Jan 2026 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 20,100 17 Jun 2025 Direct

Insider Reports Filed by Mitchell Chan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGNX REGENXBIO Inc. 06 Jan 2026 2 $0 4 Chief Financial Officer 08 Jan 2026, 16:33
RGNX REGENXBIO Inc. 01 Sep 2025 1 -$43,766 4 Chief Financial Officer 03 Sep 2025, 16:47
AVTX Avalo Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:39
AVTX Avalo Therapeutics, Inc. 28 Mar 2025 2 $0 4 Director 01 Apr 2025, 20:06
RGNX REGENXBIO Inc. 02 Jan 2025 1 $0 4 Chief Financial Officer 06 Jan 2025, 16:59
RGNX REGENXBIO Inc. 16 Sep 2024 2 $0 4 Chief Financial Officer 18 Sep 2024, 17:04
RGNX REGENXBIO Inc. 16 Sep 2024 0 $0 3 Chief Financial Officer 18 Sep 2024, 17:03
AVTX Avalo Therapeutics, Inc. 13 Aug 2024 2 $0 4 Director 14 Aug 2024, 16:56
AVTX Avalo Therapeutics, Inc. 20 Dec 2023 1 $0 4 Director 21 Dec 2023, 16:01
AVTX Avalo Therapeutics, Inc. 14 Jun 2022 1 $0 4 Director 15 Jun 2022, 16:23
AVTX Avalo Therapeutics, Inc. 01 Dec 2021 1 $0 4 Director 03 Dec 2021, 19:44
AVTX Avalo Therapeutics, Inc. 01 Dec 2021 0 $0 3 Director 03 Dec 2021, 19:42